Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
Abstract Background Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT). Methods We identified 547 patients who were treated with modern EBRT from 1997 to 2013, of whom 98% received...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2017-08-01
|
| Series: | BMC Urology |
| Online Access: | http://link.springer.com/article/10.1186/s12894-017-0250-2 |